Intensive Board Review Course in Hospice and Palliative Medicine
September 30, 2008 through October 2, 2008

Pain and Symptom Management in Patients with Advance Disease: Clinical Review for Nursing in Hospice and Palliative Care
October 1-2, 2008

12th Annual Interdisciplinary Approach to Symptom Control, Palliative and Hospice Care Conference
October 3-4, 2008

The University of Texas M. D. Anderson Cancer Center
Robert C. Hickey Auditorium
11th Floor, R. Lee Clark Clinic
1515 Holcombe Boulevard
Houston, Texas

General Information

• Intensive Board Review Course Information
• Intensive Board Review Course Agenda
• Review for Nurses Information
• Review for Nurses Agenda
• Conference Information
• Conference Agenda
• Call For Abstracts (Now Accepting - Deadline May 30, 2008)
• Poetry Submission
• Keynote Speakers and Faculty
• Registration Information
• Hotel & Transportation Information
• Houston Visitor Information

Featuring:

• Presentation of 5th Annual John Mendelsohn Award
• Presentation of the Lifetime Achievement Award
• Up-to-date, Unbiased Education from Academic Leaders
• Clinical Sessions for Symptom Control and Pain Management

Courses and Conference Organizing Committee
Board Review and Conference Chair Sriram Yennurajalingam, MD Nursing Review Course Chair Jennifer M. Clark, RN
Jennifer A. Anderson Diane Benefiel, LCSW Eduardo Bruera, MD Bianca Calderon, PharmD, BS Rony Dev, DO Nada Fadul, MD	Lisa Green, MSN, RN, AOCN Stephanie N. Jones Bill R. Kersten Martha L. Philastre, MS, MBA, FACHE Kay Swint, BSN, MSN Steve Thorney

For More Information:

CME/Conference Services
The University of Texas M. D. Anderson Cancer Center
713-792-2223 or toll free at 866-849-5866

The University of Texas M. D. Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. M. D. Anderson also requires that faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.

Agendas are subject to change because we are always striving to improve the quality of your educational experience.  M. D. Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, scheduling conflicts, and so forth.

Audio taping, videotaping or photography is prohibited.

Please let us know what specific topics, issues, or questions you wish to see addressed or emphasized in this activity.  Fax or e-mail CME/Conference Services.  All responses will be forwarded to the Program Chairs for consideration.